NCT03852537View on ClinicalTrials.gov

Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

November 17, 2020

Study Completion Date

November 17, 2020

Conditions
Pneumonia
Interventions
DRUG

Methylprednisolone

Methylprednisolone will be administered based on CRP-guided protocol outlined under 'Biomarker-adjusted steroid dosing'.

OTHER

Usual Care

Usual care as determined by the patients treatment team.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03852537 - Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia | Biotech Hunter | Biotech Hunter